PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,875 Cr | ₹3,851 Cr | ₹4,369 Cr | ₹3,851 Cr | ₹3,118 Cr |
What is the latest Total Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹4,875 Cr |
| Mar2025 | ₹3,851 Cr |
| Mar2024 | ₹4,369 Cr |
| Mar2023 | ₹3,851 Cr |
| Mar2022 | ₹3,118 Cr |
How is Total Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,875 Cr | 26.60 | |
| Mar2025 | ₹3,851 Cr | -11.87 | |
| Mar2024 | ₹4,369 Cr | 13.46 | |
| Mar2023 | ₹3,851 Cr | 23.51 | |
| Mar2022 | ₹3,118 Cr | - | |
Compare Total Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹23,577.3 Cr | -0.5% | 7.6% | -15.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -0.5% |
7.6% |
-15.1% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses